FindTrial
Sign In

Research on the mechanism of glioma stem cell three-gene score (GSC3 Score) affecting the prognosis of patients with glioma

Research on the mechanism of glioma stem cell three-gene score (GSC3 Score) affecting the prognosis of patients with glioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047914
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:none

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 80 Years

Inclusion criteria

Inclusion criteria: The images were re-read by more than 2 pathologists and diagnosed as malignant glioma.

Exclusion criteria

Exclusion criteria: 1. Cases with undetermined tumor grade. 2. The researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
cysteine glycine rich protein 1;TRIM36;synapsin 2;—

Countries

China

Contacts

Public ContactYu Shicang

The First Affiliated Hospital of Army Medical University, PLA

yushicang@163.com+86 13228685391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026